{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:08:04Z","timestamp":1740632884225,"version":"3.38.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.pathophys.2010.08.001","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T09:38:46Z","timestamp":1286185126000},"page":"151-157","source":"Crossref","is-referenced-by-count":2,"title":["Long-term normalization of blood pressure in SHR and 1-kidney 1-clip rats by synthetic precursor of stable PAF analogue without systemic effects in normotensive rats"],"prefix":"10.1016","volume":"18","author":[{"given":"Sergei I.","family":"Malekin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei V.","family":"Kotelevtsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana A.","family":"Gavrilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga E.","family":"Fadyukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna V.","family":"Golubeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina I.","family":"Grinchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir B.","family":"Koshelev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri V.","family":"Kotelevtsev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Hamet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei N.","family":"Orlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2010.08.001_bib0005","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.2063193","article-title":"Blood pressure control: special role of the kidney and body fluids","volume":"252","author":"Guyton","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2009.01.018","article-title":"Excitation\u2013contraction coupling in resistant mesenteric arteries: evidence for NKCC1-mediated pathway","volume":"379","author":"Koltsova","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0015","doi-asserted-by":"crossref","first-page":"F999","DOI":"10.1152\/ajprenal.00343.2006","article-title":"Effects of inhibition of the Na+\/K+\/2Cl\u2212 cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole","volume":"292","author":"Wang","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0020","doi-asserted-by":"crossref","first-page":"H2039","DOI":"10.1152\/ajpheart.00325.2007","article-title":"Salt sensing mechanisms in blood pressure regulation and hypertension","volume":"293","author":"Orlov","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MNH.0b013e3283360a46","article-title":"NKCC1 and hypertension: a novel therapeutic target involved in regulation of vascular tone and renal function","volume":"19","author":"Orlov","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypert."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.ki.5002773","article-title":"Calcium antagonists: do they equally protect against kidney injury","volume":"73","author":"Hart","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0035","series-title":"Calcium antagonists and the kidney","article-title":"The renal hemodynamic effects of calcium antagonists","author":"Loutzenhiser","year":"1990"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.HYP.0000184541.24700.c7","article-title":"Calcium antagonists: effects on cardio-renal risk in hypertensive patients","volume":"46","author":"Nathan","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0045","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.0000217340.40936.53","article-title":"Signaling by the angiotensin-converting enzyme","volume":"98","author":"Fleming","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ajh.2008.202","article-title":"Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system","volume":"21","author":"Kurtz","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0055","first-page":"715","article-title":"Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyl)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock","volume":"15","author":"Terashita","year":"1985","journal-title":"Adv. Prostaglandin Thromboxane Leucot. Res."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0162-3109(85)90031-1","article-title":"Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of PAF-acether","volume":"10","author":"Sanchez-Crespo","year":"1985","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000234083","article-title":"Inhibition of platelet-activating factor mediated component of guinea pig anaphylaxis by receptor antagonists","volume":"80","author":"Darius","year":"1986","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0070","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.187.11.1779","article-title":"Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet activating factor","volume":"187","author":"Ishhi","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0075","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI25426","article-title":"Anaphylactic shock depends on PI3K and eNOS-derived NO","volume":"116","author":"Cauwels","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0080","first-page":"F1504","article-title":"Platelet-activating factor is a renal vasodilator in the anesthetized rat","volume":"258","author":"Handa","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0085","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00005344-200210000-00005","article-title":"Platelet-activating factor enhanced the pressure response of endothelin-1","volume":"40","author":"Leung","year":"2002","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0090","unstructured":"F.L. Snyder, M.L. Blank, Antihypertensive neutral lipids, US patent 4,595,681, 1986."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(25)12718-3","article-title":"Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies","volume":"255","author":"Fernandez-Gallardo","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0100","unstructured":"S.I. Malekin, S.V. Kotelevtsev, Yu.V. Kotelevtsev, S.N. Orlov, Antihypertensive 1-alkyl-2-alkylcarbomoyl-glycerins and a method of the production therof. PCT\/RU2008\/000506 (WO 2010\/008312 A1), 2009."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0026-2862(85)90032-9","article-title":"Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension","volume":"30","author":"Sokolova","year":"1985","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00586267","article-title":"Altered sodium permeability, calcium binding and Na-K-ATPase activity in the red blood cell membrane in essential hypertension","volume":"371","author":"Postnov","year":"1977","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0005-2760(94)00192-2","article-title":"Paltelet-activating factor and its analogs: metabolic pathways and related intracellular proteases","volume":"1254","author":"Snyder","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0120","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1152\/physrev.2000.80.4.1669","article-title":"Role of platelet-activating factor in cardiovascular pathophysiology","volume":"80","author":"Montrucchio","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-7827(99)00016-8","article-title":"Paltelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice","volume":"39","author":"Ischii","year":"2000","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/oxfordjournals.jbchem.a003164","article-title":"Platelet-activating factor receptor","volume":"131","author":"Honda","year":"2002","journal-title":"J. Biochem."},{"issue":"Suppl. 2","key":"10.1016\/j.pathophys.2010.08.001_bib0135","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00005344-199322002-00025","article-title":"Effects of phospholipids on renal function","volume":"22","author":"Buckalew","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000071882","article-title":"Role of nitric oxide in the rnal and systematic vasodilatory responses to platelet-activating factor in the rat, in vivo","volume":"26","author":"Handa","year":"2003","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004872-199104000-00001","article-title":"Reversal of experimental hypertension","volume":"9","author":"Edmunds","year":"1991","journal-title":"J. Hypertens"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.20082150","article-title":"Anaphylactic shock depends on endothelial Gq\/G11","volume":"206","author":"Korhonen","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-291X(84)91107-0","article-title":"A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor","volume":"118","author":"Blank","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(88)90226-9","article-title":"Antagonism of the vascular effects of platelet activating factor precursor in anesthetized spontaneously hypertensive rats","volume":"145","author":"Ma","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0165","unstructured":"R.L. Magolda, P.N. Confalone, P.R. Johnson, T-thioethr-1acylaminophosphatidylcholine, compounds are structural analogs of platelet activating factor for inhibition of phospholipase A2, reduction of blood pressure, and elevation of inflammation, US Patent 4,702,864, 1987."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1254\/jjp.51.57","article-title":"Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker","volume":"51","author":"Oizumi","year":"1989","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.vascn.2007.04.001","article-title":"Pharmacokinetic-pharmacodynamic modeling of diltiazem in spontaneously hypertensive rats: a microdialysis study","volume":"56","author":"Bertera","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pathophys.2010.08.001_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1254\/jjp.47.311","article-title":"Antihypertensive action of new angiotensin converting enzyme inhibitor, (R)-3-[(S)-1-carboxy-5-(4-piperidyl)phentyl]amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine-5-aceric acid (CV-5975), in various hypertensive models","volume":"47","author":"Inada","year":"1988","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pathophys.2010.08.001_bib0185","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/bj3050689","article-title":"Platelet-activating factor: the biosynthetic and catabolic enzymes","volume":"305","author":"Snyder","year":"1995","journal-title":"Biochem. J."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468010000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468010000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:22:50Z","timestamp":1740547370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468010000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0928468010000556"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2010.08.001","relation":{},"ISSN":["0928-4680"],"issn-type":[{"type":"print","value":"0928-4680"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}